✦ LIBER ✦
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
✍ Scribed by Harbeck, N.; Schmitt, M.; Meisner, C.; Friedel, C.; Untch, M.; Schmidt, M.; Sweep, C.G.J.; Lisboa, B.W.; Lux, M.P.; Beck, T.; Hasmüller, S.; Kiechle, M.; Jänicke, F.; Thomssen, C.
- Book ID
- 120154168
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 715 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.